Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 646

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 646
---
 Form 4 filed with the SEC on May 2, 2024. Consists of (i) 17,206 shares of common stock held by Mr. Bartoszek, (ii) 2,001 shares of common stock held by his children, (iii) 1,748,473 shares of common stock held by RLB Holdings Connecticut LLC for which Mr. Bartoszek has shared voting rights and dispositive power and (iv) 41,827 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025. |

| (7) | Consists of (i) 675,230 shares of common stock held by Dr. Iadonato, (ii) 8,553 shares of common stock held in a custodial individual retirement account and (iii) 332,819 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025. |

| (8) | Consists of (i) 143,204 shares of common stock, (ii) 41,827 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025 and (iii) 14,350 shares that may be acquired pursuant to warrants that are exercisable within 60 days of March 31, 2025. |

| (9) | Consists of (i) 88,097 shares of common stock and (ii) 36,319 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025. |

| (10) | Consists of (i) 2,777 shares of common stock and (ii) 36,319 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025. |

| (11) | Consists of (i) 4,000 shares of common stock and (ii) 19,375 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025. |

| (12) | Consists of 19,375 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of March 31, 2025. |

420

INTERESTS